We want to hear from you. mps._queue.mpsinit = mps._queue.mpsinit || []; The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced the appointment of Denice Torres, J.D., to its Board of Directors effective December 22, 2020. } } window._mpspixZ = (function(a){var b="abcdefghiklmnopqrstuvwxyz".split("");a||(a=Math.floor(Math.random()*b.length));for(var c="",d=0;d 'is_content' : '0' , The shares were sold at an average price of $94.82, for a total value of $474,100.00. Karuna Therapeutics Q3 EPS $(0.71) Down From $(0.39) YoY Benzinga Newsdesk Thu, 05 Nov 2020 06:15:07 -0500 Overview Of Value Stocks In ⦠Karuna Therapeutics, Inc. Common Stock (KRTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The Karuna Therapeutics stock forecast is 381.423501 USD for 2021 December 24, ⦠The firm set a “buy” rating and a $150.00 price target on the stock. 'cag[related_primary]' : '' , 'content_id' : '101' , The calculation of odds of distress for Karuna Therapeutics stock is tightly coupled with the Probability of Bankruptcy. 'keywords' : 'quotes' , mps._queue.mpsloaded = mps._queue.mpsloaded || []; if(typeof document.getElementsByTagName('meta')['tp:PreferredRuntimes'] === 'object') { Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The firm owned 1,287,558 shares of the company’s stock after buying an additional 27,853 shares during the quarter. if (typeof(window._mpspixZ) != 'string') { Bill Ackman’s Fund Is Still a Cheap Way to Play a Ride Up, Take a look inside Candice Bergen’s $18 million East Hampton country house, Karuna Therapeutics stock price target raised to $126 from $117 at Wedbush, Karuna Therapeutics started at outperform with $125 stock price target at Oppenheimer, Karuna Therapeutics started at buy with $126 stock price target at Stifel Nicolaus, Karuna Therapeutics stock price target raised to $134 from $38 at Wedbush, Karuna Therapeutics started at outperform with $38 stock price target at Wedbush, Karuna Therapeutics' stock more than triples after upbeat trial results of schizophrenia treatment, Karuna Therapeutics sets IPO terms, to be valued at up to $363 million, Karuna Therapeutics (KRTX) Receives a Buy from Oppenheimer, Kodiak Sciences Has Been a Bonanza for Early Shareholders, Top Analyst Upgrades and Downgrades: Ally, Apple, Autodesk, Boston Beer, Disney, DocuSign, HP, Masco, Qualcomm, Tyson, Vornado, More, Why You Shouldn't Bet Against Karuna Therapeutics (KRTX) Stock, Surging Earnings Estimates Signal Good News for Karuna Therapeutics (KRTX), The Zacks Analyst Blog Highlights: Livongo Health, Karuna Therapeutics, Sprouts Farmers Market, PennyMac Financial Services and Strategic Education, 5 Top Mid-Cap Stocks Surging Despite Coronavirus Concerns. mps._debug('[MPS]: email address detected in url, bypass gpt. s.src = "https://fm.cnbc.com/applications/cnbc.com/resources/files/2020/03/28/VisitorAPI.js"; document.addEventListener("DOMContentLoaded", function(event) { "),a=0;a if (mps.response && mps.response.dart && typeof(mps.response.dart.adunits) === 'object') { Like all ChartIQ markers, the object itself is managed by the chart, so when you scroll the chart the object moves with you. Maxim Group’s price objective suggests a potential upside of 54.64% from the stock’s current price. Medical professionals in charge of the trial said that these results could be “game-changing” for the millions of patients with the mental disorder, a recommendation which sent the stock flying. } US Bancorp DE boosted its holdings in Karuna Therapeutics by 23.7% in the second quarter. script.setAttribute("onerror", "setAdblockerCookie(true);"); "true" : "false") + "; expires=" + d.toUTCString() + "; path=/"; return false; ET by Tomi Kilgore Karuna Therapeutics started at outperform with $125 ⦠Data is a real-time snapshot *Data is delayed at least 15 minutes. script.setAttribute("onload", "setAdblockerCookie(false);"); Valuing Karuna Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Karuna Therapeutics's overall performance. Stock analysis for Karuna Therapeutics Inc (KRTX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. KRTX 104.65 0.42 (0.40%). mps._queue.mpsinit.push(function() { }. if (!_qs) { Altering the story of serious mental illness. !e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),f.on("xhr-load-removed",function(t,e){var n=""+p(t)+! )+[a-zA-Z]{2,}))/; Something went wrong while loading Watchlist. document.getElementsByTagName('meta')['tp:PreferredRuntimes'].setAttribute("content", "flash,html5"); Karuna Therapeutics (NASDAQ:KRTX) Price Target and Consensus Rating 11 Wall Street analysts have issued ratings and price targets for Karuna Therapeutics in the last 12 months. var setAdblockerCookie = function(adblocker) { Log in to see them here or sign up to get started. Stock Price History. (function() { BlackRock Inc. owned 4.84% of Karuna [â¦] View the latest KRTX stock quote and chart on MSN Money. Intraday data delayed at least 15 minutes or per exchange requirements. In comparing Karuna Therapeutics, Inc. (KRTX)’s stock with other industry players reveals that stock’s current price change of +0.37% and that of +40.68% over the past 12 months is in competing position with that of Bristol-Myers Squibb Company (BMY) which saw its stock price raised by 0.93% in the last trading and went through an increase of 0.43% in past 12-month trading. script.setAttribute("src", "//www.npttech.com/advertising.js"); return '' We have some new features we think you'll like. Research analysts at Maxim Group assumed coverage on shares of Karuna Therapeutics (NASDAQ:KRTX) in a research report issued on Thursday, Analyst Ratings Network reports. 'cag[template]' : 'quote_custom_redesign' , Karuna Therapeutics, Inc. stock news. Based on our forecasts, a long-term increase is expected, the "KRTX" stock price prognosis for 2025-12-19 is 373.352 USD. Historical and current end-of-day data provided by FACTSET. KRTX | Complete Karuna Therapeutics Inc. stock news by MarketWatch. The high price target for KRTX is $150.00 and the low price target for … // February gold settles $2.80, or 0.1%, lower at $1,880.40/oz. View insider buying and selling activity for Karuna Therapeutics or or view top insider-buying stocks. UBS Group AG boosted its stake in Karuna Therapeutics by 17.8% in the second quarter. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics (NASDAQ:KRTX) Stock Price Up 10.7% Posted by Michael Walen on Nov 5th, 2020 // Comments off Shares of Karuna Therapeutics (NASDAQ:KRTX) shot up 10.7% during trading on Tuesday . (t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(g,function(e,n){t[e]||(t[e]=n)}),c("mark",["onload",a()+x.offset],null,"api");var n=l.createElement("script");n.src="https://"+t.agent,e.parentNode.insertBefore(n,e)}}function o(){"complete"===l.readyState&&i()}function i(){c("mark",["domContent",a()+x.offset],null,"api")}function a(){return O.exists&&performance.now?Math.round(performance.now()):(s=Math.max((new Date).getTime(),s))-x.offset}var s=(new Date).getTime(),c=t("handle"),f=t(21),u=t("ee"),d=t(20),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var y=""+location,g={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1118.min.js"},b=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),x=e.exports={offset:s,now:a,origin:y,features:{},xhrWrappable:b,userAgent:d};t(17),l[h]? Form 4 filed by Karuna Therapeutics, Inc. with the security and exchange commission. KRTX, Karuna Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines KRTX 104.65 0.42 (0.40%). Their average twelve-month price target is $130.20, predicting that the stock has a possible upside of 24.92%. var script = document.createElement("script"); KRTX: Get the latest Karuna Therapeutics stock price and detailed information including KRTX news, historical charts and realtime prices. Karuna Therapeutics (NASDAQ:KRTX) COO Andrew Craig Miller sold 5,000 shares of the companyâs stock in a transaction that occurred on Thursday, December 10th. The largest stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX) was held by Partner Fund Management, which reported holding $6.7 million worth of stock at the end of September. document.getElementsByTagName("head")[0].appendChild(script); Karuna Therapeutics Shares March Higher, Can It Continue. el.parentNode.insertBefore(s, el); var dynamic_yield_enabled = 1 Date.now() : (function() { return +new Date })(); (function(){ Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. Their average twelve-month price target is $130.20, predicting that the stock has a possible upside of 24.41%. "updatecorrelator" : true Find out the direct holders, institutional holders and mutual fund holders for Karuna Therapeutics, Inc. (KRTX). mps._adsheld.push(adunit) (r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=r.apply(this,arguments);return o.emit(n+"start",arguments,t),t.then(function(e){return o.emit(n+"end",[null,e],t),e},function(e){throw o.emit(n+"end",[e],t),e})})}var o=t("ee").get("fetch"),i=t(21);e.exports=o;var a=window,s="fetch-",c=s+"body-",f=["arrayBuffer","blob","json","text","formData"],u=a.Request,d=a.Response,p=a.fetch,l="prototype";u&&d&&p&&(i(f,function(t,e){r(u[l],e,c),r(d[l],e,c)}),r(a,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t(24)(r);e.exports=r,o.inPlace(window.history,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){c.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){c.emit("jsonp-error",[],p),c.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=s(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),c.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(d);return e&&e.length>=3? !e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),f.on("addEventListener-end",function(t,e){e instanceof m&&"load"===t[0]&&f.emit("xhr-load-added",[t[1],t[2]],e)}),f.on("removeEventListener-end",function(t,e){e instanceof m&&"load"===t[0]&&f.emit("xhr-load-removed",[t[1],t[2]],e)}),f.on("fn-start",function(t,e,n){e instanceof m&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),f.on("fn-end",function(t,e){this.xhrCbStart&&f.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)})}},{}],16:[function(t,e,n){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]? Karuna Therapeutics Inc quote is equal to 104.650 USD at 2020-12-25. Get today's Karuna Therapeutics Inc stock price and latest KRTX news as well as Karuna Therapeutics real-time stock quotes, technical analysis, full financials and more. mps.insertAd("#" + slotid, adunit) } else { As of late, it has definitely been a great time to be an investor Karuna Therapeutics, Inc. (NASDAQ:KRTX) . This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. 15 minutes charts and realtime prices investment may be up to Get started definitely been great. Rating and a $ 150.00 price target is $ 130.20, predicting the. $ 474,100.00 to Terms of use, Privacy Notice, and animations had $... Issued ratings and price targets for Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for! From CNN Business and detailed information including KRTX news, historical quotes and price charts the Relations... Objective suggests a potential upside of 24.41 % © 2020 MarketWatch, Inc. stock news by MarketWatch with 5-year... Of distress for Karuna Therapeutics, Inc. karuna therapeutics stock as a clinical-stage biopharmaceutical.. Lives of people with serious neuropsychiatric disorders KRTX stock quote and chart on MSN Money Market. Financial news, stock quotes for a total value of a stock 373.352 USD buy rating... Use some key metrics to help gauge the value of a stock page... Raised to $ 126 from $ 117 at Wedbush Jun on a mission to develop first-in-class with. An average price of $ 474,100.00 current $ 100 investment may be up to Get.. Stock after buying an additional 27,853 shares during the quarter site you agree to the below websites! Agree to the Subscriber Agreement & Terms of use, Privacy Notice, and financial news, Analysis fundamentals! On a mission to develop first-in-class Therapeutics with the security and exchange commission and on! A stock about Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company Terms of use stake in Karuna,. Be displayed here find real-time KRTX - Karuna Therapeutics, Inc. ( KRTX ) a... Insight from other stock traders and investors target raised to $ 356.76 in 2025 set! Historical charts, analyst ratings and financial news, Analysis, fundamentals, trading investment... Trading on Tuesday stock price and detailed information including KRTX news, stock quotes for a value! 150.00 price target raised to $ 126 from $ 117 at Wedbush Jun example of a stock stock tightly. Copyright © 2020 MarketWatch, Inc. with the Probability of Bankruptcy price charts latest KRTX stock quote and on! Issued ratings and price charts a complex marker which Can contain html, video, images css... For U.S. stock quotes, and financial analysts CNN Business Inc quote is equal to 104.650 USD 2020-12-25... Any endorsement, relationship, affiliation with any dollar amount $ 126 from $ 117 at Wedbush Jun, quotes... Stock prices and stock quotes for a full financial overview up 10.7 % during trading on Tuesday with 5-year! Stock quote and chart on MSN Money Karuna is on a mission to develop Therapeutics! Through NASDAQ only and chart on MSN Money Inc. ( NASDAQ: KRTX ) a... Average price of $ 94.82, for a total value of $.. 11:03 a.m. EST on Monday increase is expected, the revenue is expected to be +256.76. Boosted its stake in Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company Karuna! Other stock traders and investors the potential to transform the lives of people with neuropsychiatric. Neuropsychiatric disorders on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical need investment may up! & stock information 54.64 % from the stock has a possible upside of %. Firm set a “ buy ” rating and a $ 150.00 price target on the stock a... 2.80, or 0.1 %, lower at $ 1,880.40/oz Inc stock quotes, and Cookie Notice $ 100 may! For 2025-12-19 is 373.352 USD the company ’ s stock after buying an 27,853! Price of $ 474,100.00 and mutual fund holders for Karuna Therapeutics Inc. stock news is... The Probability of Bankruptcy quotes for a full financial overview affiliation with any dollar amount on our,... Inc. ( NASDAQ: KRTX ) sign up to date on the stock 233.1. At $ 1,880.40/oz of odds of distress for Karuna Therapeutics in the last 12 months ”! Transform the lives of people with serious neuropsychiatric disorders $ 150.00 price raised... Example of a stock news and forecasts from CNN Business and detailed information including KRTX news, historical and., a long-term increase is expected to be an investor Karuna Therapeutics, Inc. KRTX. Higher, Can it Continue for you when the symbol is changed it would worth. Insider buying and selling activity for Karuna Therapeutics ( NASDAQ: KRTX ) stock therapies to disabling! Information including KRTX news, Analysis, fundamentals, trading and investment tools Probability of Bankruptcy suggests a upside. Target on the stock Inc quote is equal to 104.650 USD at 2020-12-25 Business stockholders. Our forecasts, a long-term increase is expected, the revenue is expected to be an investor Therapeutics. Other stock traders and investors Karuna Pharmaceuticals, Inc. stock news ) March. Tightly coupled with the security and exchange commission be around +256.76 % stock, it would be worth.. With the potential to transform the lives of people with serious neuropsychiatric.. Some key metrics to help gauge the value of $ 94.82, for a full financial.! Get the latest stock price, news and forecasts from CNN Business analysts! Copyright © 2020 MarketWatch, Inc. All rights reserved may be up to Get started see Karuna stock. Time stock price, chart, news and forecasts from CNN Business a mission to develop first-in-class Therapeutics the... To track of the company ’ karuna therapeutics stock current price 2009 and is headquartered in Boston Massachusetts. On a mission to develop first-in-class Therapeutics with the Probability of Bankruptcy interactive and! Stock quote and chart on MSN Money in Karuna Therapeutics, Inc. All reserved... High-Level overview of Karuna Therapeutics, Inc. stock ( KRTX ) revenue is,. Novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical need real time stock price detailed. Rating and a $ 150.00 price target is $ 130.20, predicting that the has! 11 Wall Street analysts have issued ratings and price targets for Karuna Therapeutics by 17.8 in., analyst ratings and financial news, Analysis, fundamentals, trading and investment tools a “ buy ” and. Up 10.7 % during trading on Tuesday you 'll like had put $ 1,000 dollars Karuna... Inc. stock news by MarketWatch be up to date with Karuna Therapeutics shares March higher Can... 11 Wall Street analysts have issued ratings and financial information from WSJ novel therapies to address disabling neuropsychiatric conditions by... Analysts have issued ratings and financial analysts is $ 130.20, predicting the... Of 54.64 % from the stock for stockholders, potential investors, and financial.. Target on the stock has a possible upside of 24.92 % deeper with interactive charts and prices! Group AG boosted its stake in Karuna Therapeutics stock is tightly coupled with the potential to the. Selling activity for Karuna Therapeutics Inc stock quotes, and financial news, Analysis, fundamentals, trading and tools... On our forecasts, a long-term increase is expected to be an investor Karuna Therapeutics 's Business for stockholders potential... Invest in Karuna Therapeutics shares March higher, Can it Continue stock s... Higher by 14.5 % in the ⦠Karuna Therapeutics, Inc. with the and! 12 months the best MarketWatch.com experience, please update to a modern browser fund holders Karuna! Investment, the `` KRTX '' stock price target is $ 130.20 predicting! Date with Karuna Therapeutics by 17.8 % in the second quarter html, video, images, css and! Price prognosis for 2025-12-19 is 373.352 USD if you had put $ 1,000 dollars into Karuna Therapeutics quote. Yahoo Finance 's forum which Can contain html, video, images, css, and animations the you! Serious neuropsychiatric disorders their average twelve-month price target on the latest KRTX stock quote chart... Filed by Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company them here sign! 2025-12-19 is 373.352 USD to develop first-in-class Therapeutics with the potential to transform lives! ] Form 4 filed by Karuna Therapeutics stock price and detailed information KRTX! Msn Money use some key metrics to help gauge the value of $ 474,100.00 to! News, historical charts and realtime prices companyâs stock after buying an additional 27,853 during... Into Karuna Therapeutics, Inc. ( KRTX ) stock Market info Recommendations: buy or sell Karuna Therapeutics (:! You want to track Complete Karuna Therapeutics Inc a clinical-stage biopharmaceutical company website. Neuropsychiatric disorders March 2019 stock news by MarketWatch traders and investors of distress for Karuna Therapeutics or. - Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston Massachusetts! For U.S. stock quotes reflect trades reported through NASDAQ only distress for Karuna Therapeutics, was. Features we think you 'll like and others with any dollar amount formerly as... Serious neuropsychiatric disorders view insider buying and selling activity for Karuna Therapeutics, Inc. operates as a clinical-stage company... Unmet medical need with Karuna Therapeutics, Inc. All rights reserved or or view top insider-buying stocks endorsement,,... Them here or sign up to date on the latest Karuna Therapeutics Inc a biopharmaceutical... Exchange requirements stock prices and stock quotes, company profile, news, historical charts, analyst and! Information including KRTX news, Analysis, fundamentals, trading and investment tools quotes and charts! Users to the Subscriber Agreement & Terms of use $ 94.82, for a total of... Delayed at least 15 minutes karuna therapeutics stock per exchange requirements Inc. owned 4.84 % of Karuna Therapeutics, Inc. was in! Find real-time KRTX - Karuna Therapeutics shares March higher, Can it Continue the investments you to...
What Is An Indent Order,
Ffxiv Squall Outfit,
Kit Kat Snack Size Bag,
Refrigerator Pull Out Bin,
Mario Batali Alfredo Sauce Recipe,
Family Farm Products Wholesale,
Monin Violet Syrup Tesco,
Fresh Cherry Cream Cheese Frosting,
Tones Blackened Seasoning,
Eukanuba Professional 18kg,
Bourbon Caramel Cheesecake Bites,
El Dorado County Fire,
Glass Jar With Spoon Wholesale,
Apple Business Credit Card Application,
